Innovatus Life Sciences Offshore Fund I-A, LP — Form D/A
Innovatus Life Sciences Offshore Fund I-A, LP of NEW YORK, NY, a pooled investment fund, filed a Form D amendment with the SEC on 2025-03-21. $10.0M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2025-03-21
- Form: D/A
- Accession: 0001811630-25-000002
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Amount sold: $10.0M
- Minimum investment: $2.0M
- Investors: 1
- Date of first sale: 2019-09-30
- Security types: fund interests
- SEC file number: 021-368025
Issuer
- Name: Innovatus Life Sciences Offshore Fund I-A, LP
- CIK: 0001811630
- Entity type: Limited Partnership
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2019
- Address: 777 THIRD AVENUE, 25TH FLOOR, NEW YORK, NY, 10017
- Phone: 212.698.4595
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Andrew Dym | Executive Officer | New York, NY |
| Andrew Hobson | Executive Officer | New York, NY |
| N/A Innovatus Flagship Offshore Parent GP, LLC | Executive Officer | Grand Cayman, E9 |
| N/A Innovatus Life Sciences Offshore GP, LP | Executive Officer | Grand Cayman, E9 |
| David Schiff | Executive Officer | New York, NY |
| Sean Wilke | Executive Officer | New York, NY |
| N/A Innovatus Capital Partners, LLC | Promoter | New York, NY |
| Joseph Schottland | Executive Officer | New York, NY |
Other filings by this issuer (2)
More